Skip to main content
. Author manuscript; available in PMC: 2022 Nov 17.
Published in final edited form as: Pediatr Allergy Immunol. 2022 Jun;33(6):e13802. doi: 10.1111/pai.13802

Table 3.

Sensitivity analysis for rs12091010 and rs943126 in individuals from the discovery stage.

Exacerbations in the last 6 months Exacerbations in the last 12 months
European-descent populations European-descent populations Multi-ancestry meta-analysis
rsID OR (95% CI) P Cochran’s Q P OR (95% CI) P Cochran’s Q P OR (95% CI) P Cochran’s Q P
rs12091010 0.84 (0.67–1.04) 1.08×10−1 5.14 ×10−1 0.86 (0.72–1.03) 9.13 ×10−2 6.25 ×10−1 0.82 (0.74–0.90) 3.45 ×10−5 4.84 ×10−1
rs943126 0.78 (0.64–0.96) 2.13 ×10−2 8.61 ×10−1 0.88 (0.74–1.04) 1.26 ×10−1 8.28 ×10−1 0.85 (0.78–0.93) 3.29 ×10−4 7.50 ×10−2

Abbreviations: 95% CI: 95% confidence interval; OR: Odds ratio; P: P-value.